Kong D, Li Y, Wang Z, Sarkar FH (2011). “Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?”. Cancers (Basel)3 (1): 716–729. doi:10.3390/cancers30100716. PMID21643534.
Thiery JP, Acloque H, Huang YJR, Nieto MA (2009). “Epithelial-Mesenchymal Transitions in Development and Disease”. Cell139 (5): 871–890. doi:10.1016/j.cell.2009.11.007. PMID19945376.
Peinado H, Olmeda D, Cano A (2007). “Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?”. Nat. Rev. Cancer7 (6): 415–428. doi:10.1038/nrc2131. PMID17508028.
Yang J, Weinberg RA (2008). “Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis”. Dev. Cell14: 818–829. doi:10.1016/j.devcel.2008.05.009. PMID18539112.
De Craene B, Berx G (2013). “Regulatory networks defining EMT during cancer initiation and progression”. Nat. Rev. Cancer13: 97–110. doi:10.1038/nrc3447. PMID23344542.
Herfs M, Hubert P, Suarez-Carmona M, Reschner A, Saussez S, Berx G, Savagner P, Boniver J, Delvenne P (2010). “Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma”. Am. J. Pathol.176 (4): 1941–1949. doi:10.2353/ajpath.2010.090804. PMID20150431.
Boldrup L, Coates PJ, Gu X, Nylander K (2007). “ΔNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck”. J. Pathol.213 (4): 384–391. doi:10.1002/path.2237. PMID17935121.
Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (2008). “The role of ATF-2 in oncogenesis”. BioEssays30 (4): 314–327. doi:10.1002/bies.20734. PMID18348191.
Huber MA, Beug H, Wirth T (2004). “Epithelial-mesenchymal transition: NF-κB takes center stage”. Cell Cycle3 (12): 1477–1480. doi:10.4161/cc.3.12.1280. PMID15539952.
Katoh Y, Katoh M (2008). “Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA”. Int. J. Mol. Med.22 (3): 271–275. doi:10.3892/ijmm_00000019. PMID18698484.
Hay ED (2005). “The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it”. Dev. Dyn.233 (3): 706–720. doi:10.1002/dvdy.20345. PMID15937929.
Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, Kikkawa F (2007). “Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells”. Int. J. Oncol.31: 277–283. doi:10.3892/ijo.31.2.277. PMID17611683.
Mani SA, Guo W, Liao MJ, Eaton NE, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang1, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008). “The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells”. Cell133 (4): 704–715. doi:10.1016/j.cell.2008.03.027. PMID20150431.
Singh A, Settleman J (2010). “EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer”. Oncogene29: 4741–4751. doi:10.1038/onc.2010.215.
Gershengorn MC, Hardikar AA, Wei C et al. (2004). “Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells”. Science306: 2261–2264. doi:10.1126/science.1101968. PMID15564314.
Gershengorn MC, Geras-Raaka E, Hardikar AA et al. (2005). “Are better islet cell precursors generated by epithelial-to-mesenchymal transition?”. Cell Cycle4: 380–382. doi:10.4161/cc.4.3.1538. PMID15711124.
Atouf F, Park CH, Pechhold K et al. (2007). “No evidence for mouse pancreatic beta-cell epithelial-mesenchymal transition in vitro”. Diabetes56: 699–702. doi:10.2337/db06-1446. PMID17327438.
Chase LG, Ulloa-Montoya F, Kidder BL et al. (2007). “Islet-derived fibroblast-like cells are not derived via epithelial-mesenchymal transition from Pdx-1 or insulin-positive cells”. Diabetes56: 3–7. doi:10.2337/db06-1165. PMID17110468.
Russ HA, Bar Y, Ravassard P et al. (2008). “In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing”. Diabetes57: 1575–1583. doi:10.2337/db07-1283. PMID18316362.
Joglekar MV, Joglekar VM, Joglekar SV et al. (2009). “Human fetal pancreatic insulin-producing cells proliferate in vitro”. J. Endocrinol.201: 27–36. doi:10.1677/JOE-08-0497. PMID19171567.
nih.gov
pubmed.ncbi.nlm.nih.gov
Kong D, Li Y, Wang Z, Sarkar FH (2011). “Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?”. Cancers (Basel)3 (1): 716–729. doi:10.3390/cancers30100716. PMID21643534.
Thiery JP, Acloque H, Huang YJR, Nieto MA (2009). “Epithelial-Mesenchymal Transitions in Development and Disease”. Cell139 (5): 871–890. doi:10.1016/j.cell.2009.11.007. PMID19945376.
Peinado H, Olmeda D, Cano A (2007). “Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?”. Nat. Rev. Cancer7 (6): 415–428. doi:10.1038/nrc2131. PMID17508028.
Yang J, Weinberg RA (2008). “Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis”. Dev. Cell14: 818–829. doi:10.1016/j.devcel.2008.05.009. PMID18539112.
De Craene B, Berx G (2013). “Regulatory networks defining EMT during cancer initiation and progression”. Nat. Rev. Cancer13: 97–110. doi:10.1038/nrc3447. PMID23344542.
Herfs M, Hubert P, Suarez-Carmona M, Reschner A, Saussez S, Berx G, Savagner P, Boniver J, Delvenne P (2010). “Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma”. Am. J. Pathol.176 (4): 1941–1949. doi:10.2353/ajpath.2010.090804. PMID20150431.
Boldrup L, Coates PJ, Gu X, Nylander K (2007). “ΔNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck”. J. Pathol.213 (4): 384–391. doi:10.1002/path.2237. PMID17935121.
Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (2008). “The role of ATF-2 in oncogenesis”. BioEssays30 (4): 314–327. doi:10.1002/bies.20734. PMID18348191.
Huber MA, Beug H, Wirth T (2004). “Epithelial-mesenchymal transition: NF-κB takes center stage”. Cell Cycle3 (12): 1477–1480. doi:10.4161/cc.3.12.1280. PMID15539952.
Katoh Y, Katoh M (2008). “Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA”. Int. J. Mol. Med.22 (3): 271–275. doi:10.3892/ijmm_00000019. PMID18698484.
Hay ED (2005). “The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it”. Dev. Dyn.233 (3): 706–720. doi:10.1002/dvdy.20345. PMID15937929.
Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, Kikkawa F (2007). “Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells”. Int. J. Oncol.31: 277–283. doi:10.3892/ijo.31.2.277. PMID17611683.
Mani SA, Guo W, Liao MJ, Eaton NE, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang1, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008). “The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells”. Cell133 (4): 704–715. doi:10.1016/j.cell.2008.03.027. PMID20150431.
Gershengorn MC, Hardikar AA, Wei C et al. (2004). “Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells”. Science306: 2261–2264. doi:10.1126/science.1101968. PMID15564314.
Gershengorn MC, Geras-Raaka E, Hardikar AA et al. (2005). “Are better islet cell precursors generated by epithelial-to-mesenchymal transition?”. Cell Cycle4: 380–382. doi:10.4161/cc.4.3.1538. PMID15711124.
Atouf F, Park CH, Pechhold K et al. (2007). “No evidence for mouse pancreatic beta-cell epithelial-mesenchymal transition in vitro”. Diabetes56: 699–702. doi:10.2337/db06-1446. PMID17327438.
Chase LG, Ulloa-Montoya F, Kidder BL et al. (2007). “Islet-derived fibroblast-like cells are not derived via epithelial-mesenchymal transition from Pdx-1 or insulin-positive cells”. Diabetes56: 3–7. doi:10.2337/db06-1165. PMID17110468.
Russ HA, Bar Y, Ravassard P et al. (2008). “In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing”. Diabetes57: 1575–1583. doi:10.2337/db07-1283. PMID18316362.